DS LifeScience 0115
- 1. DS LifeScience Consulting Corporate & Business Development Expertise 1 P.O. Box 1091 Rancho Santa Fe, California 92067 Phone: (760) 525-7262 E-Mail: dslack62@gmail.com Providing client-focused biotech & pharma partnering & corporate development services since 2004 Over 20 years’ operating experience brings insights, analytical capabilities and discipline Track record of crafting deals valued in excess of $1 billion Global network enables targeted partner out-reach to drive optimal results Hybrid compensation model that aligns incentives with clients’ goals & objectives
- 2. DS LifeScience Consulting Corporate & Business Development Expertise 2 P.O. Box 1091 Rancho Santa Fe, California 92067 Phone: (760) 525-7262 E-Mail: dslack62@gmail.com PARTNERING TRANSACTION SERVICES Deep experience base in running partnering campaigns for in- or out- licensing; asset sales; strategic alliances and structured M&A Identify, assess & prioritize partnering opportunities Identification of, and out-reach to potential partners Craft partnering pitch Support due diligence Financial analyses Structure deal terms & relationship for success Negotiate and close deal
- 3. DS LifeScience Consulting Corporate & Business Development Expertise 3 P.O. Box 1091 Rancho Santa Fe, California 92067 Phone: (760) 525-7262 E-Mail: dslack62@gmail.com CORPORATE DEVELOPMENT SERVICES Strategic advisor to senior management team or Board of Directors Business Plan development for emerging companies; spin-outs, divisions or products of existing companies Strategic Financial Plan development Financing strategy, valuation and comparable metrics Support for Senior Management and/or Board decisions
- 4. DS LifeScience Consulting Corporate & Business Development Expertise 4 P.O. Box 1091 Rancho Santa Fe, California 92067 Phone: (760) 525-7262 E-Mail: dslack62@gmail.com TRACK RECORD Provided leadership for transactions to maximize financial reward while achieving strategic objectives Biotech, pharma, investor (“buy” & “sell side”) perspectives Industry-leading discovery & development partnerships Innovative ventures for investment and/or spin-out Domain expertise spanning small molecule, peptide, antibody, gene therapy, antisense and devices across therapeutic areas
- 5. DS LifeScience Consulting Corporate & Business Development Expertise 5 P.O. Box 1091 Rancho Santa Fe, California 92067 Phone: (760) 525-7262 E-Mail: dslack62@gmail.com PARTIAL LIST OF TRANSACTIONS TRANSACTION COMPANIES $67 million series B private financing Novimmune – Rosetta Capital et al $6 million series A venture financing Thomas McNerney Partners – Altair Therapeutics In-license & discovery collaboration with equity stake Altair Therapeutics – Isis Pharmaceuticals Out-license / drug discovery collaboration with equity investment Xenome – Amylin Pharmaceuticals (BMS) Out-license / drug discovery collaboration Raven biotechnologies – Abbott (Abbvie) $440 million out-license / drug discovery-development strategic alliance with equity investment, and expansion after year 1 Isis Pharmaceuticals – Eli Lilly R&D collaboration & option agreement Isis Pharmaceuticals – Merck & Co. R&D collaboration & option agreement Isis Pharmaceuticals – J&J Pharma (Janssen) $450 million in-license / drug discovery-development strategic alliance with equity investment Aventis Pharma (Sanofi) – Millennium (Takeda) Out-license / drug development, manufacture and commercialization for Phase III drug candidate Isis Pharmaceuticals – Ciba Vision (Novartis)
- 6. DS LifeScience Consulting Corporate & Business Development Expertise 6 P.O. Box 1091 Rancho Santa Fe, California 92067 Phone: (760) 525-7262 E-Mail: dslack62@gmail.com ENGAGEMENT TERMS Hybrid model aligns incentives with clients’ goals & objectives Monthly professional fee plus expense reimbursement Share in successful outcomes Equity as part of compensation considered
- 7. DS LifeScience Consulting Corporate & Business Development Expertise 7 P.O. Box 1091 Rancho Santa Fe, California 92067 Phone: (760) 525-7262 E-Mail: dslack62@gmail.com David Slack, MBA, Managing Director has a track record of innovation in business development, fundraising in senior management roles at public & private biotech as well as large pharma companies. His deal-making experience encompasses major corporate partnerships, spin-outs, start-ups and financings. At DS LifeScience, David provided corporate development, partnering and investment advisory services to range of organizations including Allergan Pharmaceuticals, Sequenom, Raven biotechnologies, Xenome, Thomas McNerney Partners, Altair Therapeutics, BioAtla, the Assay Depot, the Sanford Burnham Medical Research Institute; he served as founding CEO for Kinagen, and served as Head of Corporate & Business Development for Novimmune SA. Prior to DS LifeScience Consulting, David served as Vice President for Business Development at Isis Pharmaceuticals, where he was responsible for several major partnerships. Prior to Isis, David served in senior positions as Rhône-Poulenc Rorer and Aventis Pharmaceuticals, where he was responsible for multiple major strategic partnerships. To discuss how we may work together, please contact: DS LifeScience Consulting David Slack, Managing Director Telephone: (760) 525-7262 Email: dslack62@gmail.com